rxstat › Shortages › Atorvastatin Amlodipine
Atorvastatin Amlodipine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Atorvastatin Amlodipine products are in shortage in Canada (1 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 28, 2026.
In shortage since
Jun 23, 2026
Est. full return
Aug 28, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · since Jun 23, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-AMLODIPINE/ATORVASTATIN
80MG
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362783 · ended Jul 18, 2025 · Demand increase for the drug.
ResolvedMYLAN-AMLODIPINE/ATORVASTATIN
40MG
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362775 · ended Jul 18, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-AMLODIPINE/ATORVASTATIN
40MG
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362813 · ended Jul 18, 2025 · Other (Please describe in comments)
ResolvedCADUET
80MG
5MG · TABLET · BGP PHARMA ULC
DIN 02273276 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Sep 5, 2024 · Disruption of the manufacture of the drug.
ResolvedCADUET
80MG
10MG · TABLET · UPJOHN CANADA ULC
DIN 02273314 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
ResolvedMYLAN-AMLODIPINE/ATORVASTATIN
80MG
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362821 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
AvoidedCADUET
10MG
10MG · TABLET · BGP PHARMA ULC
DIN 02273284 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Jun 6, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-AMLODIPINE-ATORVASTATIN
40MG
5MG · TABLET · APOTEX INC
DIN 02411288 · ended Jun 6, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 56 reports. All reports are on file with Health Canada.
What's happening
Atorvastatin Amlodipine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Atorvastatin Amlodipine is classified under “LIPID MODIFYING AGENTS, COMBINATIONS” (ATC C10BX).
Recent changes
Common questions
When will Atorvastatin Amlodipine be back in stock in Canada?
The latest manufacturer estimate is Aug 28, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Atorvastatin Amlodipine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.